Publications by authors named "Nancy Harold"

Claim this Profile
P
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
Ravi A Madan, Fatima H Karzai, Yang-Min Ning, Bamidele A Adesunloye, Xuan Huang, Nancy Harold

BJU Int· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.
Fatima H Karzai, Andrea B Apolo, Liang Cao, Ravi A Madan, David E Adelberg, Nancy Harold

BJU Int· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer.
Carter Van Waes, Clint T Allen, Deborah Citrin, David Gius, A Dimetrios Colevas, Nancy A Harold

Int J Radiat Oncol Biol Phys· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
Gregory D Leonard, Maurice A Wright, Mary G Quinn, Suzanne Fioravanti, Nancy Harold

BMC Cancer· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.
Maurice A Wright, Geraldine Morrison, Pengxin Lin, Gregory D Leonard, Dat Nguyen, Nancy Harold

Clin Cancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin.
Jean L Grem, Mary G Quinn, Bruce Keith, Brian P Monahan, J Michael Hamilton, Nancy Harold

Cancer Chemother Pharmacol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule.
Xiao-Du Guo, Nancy Harold, M Wasif Saif, Barbara Schuler, Eva Szabo

Cancer Chemother Pharmacol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
Jean L Grem, Nancy Harold, Bruce Keith, Alice P Chen, Viven Kao

Clin Cancer Res· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of two weekly schedules of oral eniluracil given with fluorouracil and leucovorin on the duration of dihydropyrimidine dehydrogenase inhibition.
Bruce Keith, Xiao-Du Guo, Suzanne Zentko, Nancy Harold, Barbara Schuler

Clin Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis